D30.3 — Benign neoplasm of bladder
Is D30.3 billable?
Yes — D30.3 is billable for FY2027. D30.3 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D30.3 may be submitted for encounters from October 1, 2026 through September 30, 2027.
D30.3 at a glance
| Code | D30.3 |
|---|---|
| Description | Benign neoplasm of bladder |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does D30.3 group to?
D30.3 sits in MDC 11 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 656Kidney and Ureter Procedures for Neoplasm with MCCsurgical
- 657Kidney and Ureter Procedures for Neoplasm with CCsurgical
- 658Kidney and Ureter Procedures for Neoplasm without CC/MCCsurgical
Inclusion terms
Alternative wording in documentation that is classified to D30.3.
- Benign neoplasm of ureteric orifice of bladder
- Benign neoplasm of urethral orifice of bladder
How long has D30.3 existed?
D30.3 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.
Which codes are confused with D30.3?
ICD-10-CM declares these codes mutually exclusive with D30.3 — exactly one of each pair can be correct for a given encounter.